The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV. Prophylactic use of ...
Adolescents and young adults on TMP-SMX have a higher 30-day risk of acute respiratory failure than those on amoxicillin or cephalosporins. The study supports the FDA's warning about TMP-SMX, with ...
A collaboration between Vanderbilt University and Washington University researchers produced a population-based cohort study suggesting first-trimester treatment of urinary tract infection (UTI) with ...
Infants of mothers treated in the first trimester of pregnancy with trimethoprim/sulfamethoxazole (TMP-SMX) antibiotics for urinary tract infection (UTI) appeared to ...
Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...
The 30-day risk of a hospital visit for acute respiratory failure was higher among healthy adolescents and young adults receiving trimethoprim-sulfamethoxazole (TMP-SMX) compared with amoxicillin or ...
In a recent study published in JAMA Network Open, researchers evaluated the risk of congenital malformations following antibiotic treatment for urinary tract infection (UTI) during the first trimester ...
Hospital visits for acute respiratory failure occurred more frequently among healthy adolescents and young adults receiving trimethoprim-sulfamethoxazole versus amoxicillin or cephalosporins. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results